Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
South Asian Journal of Cancer|December 25, 2025
Haploidentical Stem Cell Transplantation for Hematological Disorders: Real-World Experience from IndiaPallavi Mehta, Vishvdeep Khushoo
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|June 26, 2023
Is Old (Fludrabine/Busulfan/Cyclophosphamide/rAntiThymocyteGlobulin) Conditioning Still Gold for Allogeneic Transplants in Transfusion Dependent Beta-Thalassemia of All Risk Categories in 21st Century?D M Pallavi Mehta, Vishvdeep Khushoo
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 12, 2021
Retrospective Study of Carfilzomib-Pomalidomide-Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients in a Tertiary Care Hospital in IndiaPallavi Mehta, Neha Yadav, Bhaarat Folbs, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|July 16, 2021
Study of Three Cases of Primary Refractory T Cell ALLReema Singh, Narender Tejwani, Narendra Agrawal, et al.
Therapeutic Advances in Infectious Disease|April 29, 2021
Study of clinical characteristics, risk factors and outcomes for tuberculosis post allogeneic stem cell transplant: never count it outJyotsna Kapoor, Sumeet Prakash Mirgh, Vishvdeep Khushoo, et al.
Annals of Hematology|April 3, 2021
Experience with combination of hydroxyurea and low-dose thalidomide in transfusion-dependent beta thalassemia patientsDinesh Bhurani, Jyotsna Kapoor, Neha Yadav, et al.
South Asian Journal of Cancer|January 5, 2022
A Retrospective Cohort Study of Upfront Nilotinib in Chronic Myeloid Leukemia: A Single-Center ExperienceReema Singh, Jyotsna Kapoor, Rayaz Ahmed, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 2, 2022
High Risk Acute Promyelocytic Leukemia - An Enigma for Hematologists: Optimizing Treatment with APML-4 ProtocolJyotsna Kapoor, Sumeet Prakash Mirgh, Narendra Agrawal, et al.
American Journal of Blood Research|July 29, 2021
Hypomethylating agents+venetoclax induction therapy in acute myeloid leukemia unfit for intensive chemotherapy - novel avenues for lesser venetoclax duration and patients with baseline infections from a developing countrySumeet Mirgh, Archana Sharma, Mohammad Rizwan Mohammad Anwar Shaikh, et al.
Indian Journal of Cancer|October 3, 2023
Second stem cell transplantation for treatment of relapsed/refractory multiple myeloma after first autologous stem cell transplant: A 15-year retrospective institutional analysisNeha Yadav, Sumeet P Mirgh, Mukul Aggarwal, et al.
Pageof 4